These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 18239401)

  • 1. Fistulizing Crohn's disease.
    Felley C; Mottet C; Juillerat P; Pittet V; Froehlich F; Vader JP; Michetti P; Gonvers JJ
    Digestion; 2007; 76(2):109-12. PubMed ID: 18239401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fistulizing Crohn's disease.
    Felley C; Mottet C; Juillerat P; Froehlich F; Burnand B; Vader JP; Michetti P; Gonvers JJ
    Digestion; 2005; 71(1):26-8. PubMed ID: 15711045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease.
    Van Assche G; Vanbeckevoort D; Bielen D; Coremans G; Aerden I; Noman M; D'Hoore A; Penninckx F; Marchal G; Cornillie F; Rutgeerts P
    Am J Gastroenterol; 2003 Feb; 98(2):332-9. PubMed ID: 12591051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T; Göke B; Sackmann M
    Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
    Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
    Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
    de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
    Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: medical, surgical and radiological management of perianal Crohn's fistulas.
    Tozer PJ; Burling D; Gupta A; Phillips RK; Hart AL
    Aliment Pharmacol Ther; 2011 Jan; 33(1):5-22. PubMed ID: 21083581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?
    Gaertner WB; Decanini A; Mellgren A; Lowry AC; Goldberg SM; Madoff RD; Spencer MP
    Dis Colon Rectum; 2007 Nov; 50(11):1754-60. PubMed ID: 17899271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: The medical treatment of Crohn's perianal fistulas.
    Schwartz DA; Herdman CR
    Aliment Pharmacol Ther; 2004 May; 19(9):953-67. PubMed ID: 15113362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: treatment of perianal fistulizing Crohn's disease.
    Rutgeerts P
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():106-10. PubMed ID: 15352905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed?
    Tanaka S; Matsuo K; Sasaki T; Nakano M; Sakai K; Beppu R; Yamashita Y; Maeda K; Aoyagi K
    Hepatogastroenterology; 2010; 57(97):3-7. PubMed ID: 20422862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: Medical therapy for fistulizing Crohn's disease.
    Bressler B; Sands BE
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1283-93. PubMed ID: 17059510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perianal fistulizing Crohn's disease: a call to action.
    Kamm MA; Ng SC
    Clin Gastroenterol Hepatol; 2008 Jan; 6(1):7-10. PubMed ID: 18063415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of perianal fistulizing Crohn's disease: a conservative approach].
    Dignass AU
    Dtsch Med Wochenschr; 2005 Aug; 130(34-35):1968. PubMed ID: 16123902
    [No Abstract]   [Full Text] [Related]  

  • 16. Infliximab in fistulizing Crohn's disease.
    Osterman MT; Lichtenstein GR
    Gastroenterol Clin North Am; 2006 Dec; 35(4):795-820. PubMed ID: 17129814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
    Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD
    Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report.
    van der Hagen SJ; Baeten CG; Soeters PB; Russel MG; Beets-Tan RG; van Gemert WG
    Dis Colon Rectum; 2005 Apr; 48(4):758-67. PubMed ID: 15750797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of fistulizing Crohn's disease.
    Judge TA; Lichtenstein GR
    Gastroenterol Clin North Am; 2004 Jun; 33(2):421-54, xi-xii. PubMed ID: 15177547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination biological therapy for fistular Crohn's disease: clinical demonstration].
    Knyazev OV; Parfenov AI; Shcherbakov PL; Konoplyannikov AG; Ruchkina IN; Lischchinskaya AA
    Ter Arkh; 2014; 86(2):102-5. PubMed ID: 24772517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.